Back to top

MANAGEMENT CONSULTING AGREEMENT

Consulting Services Agreement

MANAGEMENT CONSULTING AGREEMENT | Document Parties: NEUROKINE PHARMACEUTICALS INC. | NEUROKINE PHARMACEUTICALS INC You are currently viewing:
This Consulting Services Agreement involves

NEUROKINE PHARMACEUTICALS INC. | NEUROKINE PHARMACEUTICALS INC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: MANAGEMENT CONSULTING AGREEMENT
Date: 8/7/2009

MANAGEMENT CONSULTING AGREEMENT, Parties: neurokine pharmaceuticals inc. , neurokine pharmaceuticals inc
50 of the Top 250 law firms use our Products every day

MANAGEMENT CONSULTING AGREEMENT

 

THIS MANAGEMENT CONSULTING AGREEMENT (the "Agreement") is entered into as of April 1, 2009 (the “Effective Date”).

 

BETWEEN:

 

NEUROKINE PHARMACEUTICALS INC.

a corporation incorporated under the laws of British Columbia having its principal place of business at 1275 West 6th Avenue, Vancouver, British Columbia V6H 1A6

 

(the ”Company“)

 

AND:

 

PENNY GREEN

an attorney and businessperson having her principal place of business at 925 West Georgia Street, Suite 1820, Vancouver, British Columbia V6C 3L2

 

(the ”Consultant”)

 

WHEREAS:

 

A.

The Company is engaged in the research, development and commercialization of pharmaceutical products; and

 

B.

The Company wishes to engage the services of the Consultant as Vice-President, Finance, of the Company.

 

THIS AGREEMENT WITNESSES that in consideration of the premises and mutual covenants contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, hereby agree as follows:

 

1.

ENGAGEMENT AND APPOINTMENT

 

1.1

The Company hereby engages and appoints the Consultant to serve as the Vice-President, Finance, of the Company and to provide the Services (as defined below) in accordance with and subject to the terms and conditions of this Agreement and the Consultant hereby accepts such engagement and appointment

 

1.2

The appointment of the Consultant as Vice-President, Finance, under this Agreement shall be subject to the provisions of the Articles of the Company regarding the appointment, compensation, indemnification, disqualification and removal of officers.

 

 

1


 


 

2.

TERM

 

2.1

The Term of this Agreement shall be for an initial period of one (1) year commencing on the Effective Date and ending 12 months thereafter unless earlier terminated in accordance with section 7 (the “ Term ”).

 

3.

SERVICES

 

3.1

In consideration of the compensation payable in accordance with section 5, the Consultant hereby agrees to use her best efforts to perform or cause to be performed the following services:

 

 

(a)

assisting the Company to develop and manage the execution of its business plan;

 

 

(b)

overseeing and performing all services reasonably required to publicly list the common stock of the Company on the Over the Counter Bulletin Board (“ OTCBB ”), including the following work:

 

 

(i)

overseeing the engagement of an auditor for the Company;

 

 

(ii)

communicating with the accountants and auditor of the Company to facilitate the preparation of financial statements;

 

 

(iii)

securing a market maker for the Company;

 

 

(iv)

engaging a transfer agent for the Company;

 

 

(v)

soliciting and securing a minimum of 33 investors for the Company in order to complete the Company’s OTCBB listing; and

 

 

(vi)

overseeing the preparation of a registration statement on Form S-1 for the Company;

 

 

(c)

introducing the Company to broker/dealers; and

 

 

(d)

overseeing and performing all corporate finance work for the Company during the Term, including, but not limited to, due diligence and the  negotiation and preparation of financing agreements.

 

(collectively, the “Services”)

 

3.2

The Consultant shall devote as much time, attention and energy to the business and affairs of the Company as may be reasonably necessary to perform the Services.

 

 

2


 

 

4. 

RELATIONSHIP AMONG THE PARTIES

 

4.1

Nothing contained in this Agreement shall be construed to (i) constitute the parties as joint venturers, partners, co-owners or otherwise as participants in a joint undertaking; (ii) constitute the Consultant as an employee of the Company; or (iii) authorize or permit the Consultant or any director, officer, employee, agent or other person acting on its behalf to incur any obligation of any kind, either express or implied, or do, sign or execute any things, deeds, or documents which may have the effect of legally binding or obligating the Company in any manner in favour of any individual, business, trust, unincorporated association, corporation, partnership, joint venture, limited liability company or other entity of any kind.  The Company and the Consultant agree that the relationship among the parties shall be that of independent contractor.

 

5. 

COMPENSATION

 

5.1

In full consideration of the Services, the Company shall issue to the Consultant 192,000 common shares of the Company’s capital stock at a rate of 16,000 per month throughout the Term, payable in four installments of 48,000 shares at the conclusion of each 3 month period during the Term.  Each issuance of shares by the Company to the Consultant under this Agreement shall be subject to the terms of the subscription agreement in the form attached hereto as Schedule “A’.  The shares shall issued by the Company to the Consultant hereunder shall be assessed at their fair market value at the time of issuance.

 

6. 

SERVICES NOT EXCLUSIVE

 

6.1

The Company acknowledges that Consultant is engaged in other business and professional activities and the Consultant shall not be restricted from engaging in such activities during the term of this Agreement.

 

7. 

SUSPENSION AND TERMINATION.

 

7.1

Termination for Cause by Company .  The Company may terminate this Agreement for cause at any time and without notice in the event the Consultant engages in any negligence, dishonesty, fraud, insubordination, serious misconduct or anything else that would constitute cause at law. The failure by the Company to rely on this provision in any given instance or instances shall not constitute a precedent or be deemed a waiver.

 

7.2

Termination for Cause by Consultant .  The Consultant may terminate this Agreement for cause at any time without notice in the event the Company engages in any negligence, dishonesty, fraud, insubordination, material misrepresentation, serious misconduct or anything else that would constitute cause at law. The failure by the Consultant to rely on this provision in any given instance or instances shall not constitute a precedent or be deemed a waiver.  The Consultant shall also be entitled to terminate this Agreement in the event of the Company’s insolvency, voluntary or involuntary bankruptcy, receivership or assignment for the benefit of creditors.

 

7.3

Force Majeure .  The parties shall have the right to suspend this Agreement in the event of force majeure at any time, provided the Company provides prompt written notice of such suspension to the Consultant.  The suspension of this Agreement shall not relieve either party of their obligations hereunder.  The Company and the Consultant shall each have the right to terminate this Agreement by giving written notice to the other party where an event or events of force majeure continues for a continuous period of 20 consecutive business days or 30 days in the aggregate during the Term.

 

7.4

Effect of Termination .  Upon any termination in accordance with this Agreement, all obligations of the parties shall cease provided that the Consultant shall be entitled to receive any compensation accrued prior to the effective date of such termination.  Notwithstanding the foregoing, the provisions of sections 8 and 9 shall survive the termination of this Agreement.

 

 

3


 


 

8. 

CONFIDENTIALITY

 

8.1

The Consultant shall not, without the prior authorization of the Company, at any time during the Term or thereafter, disclose to any person, firm, association or corporation other than the directors, officers or employees of the Company, the private or business affairs of the Company or its affiliated companies, or any other information of a private or confidential nature concerning the Company or its affiliated companies (the “ Confidential Information ”) including, without limitation:

 

 

(a)

information concerning trade secrets, products, technology, sales literature and brochures, forms, business policies and concepts, and contracts of the Company;

 

 

(b)

information concerning manufacturing and production, pricing and sales policies, and marketing techniques and concepts in respect of products and services provided or to be provided by the Company;

 

 

(c)

names, addresses and contact information of past, present or prospective customers, employees, shareholders, officers, directors or associates of the company, or any person or entity having a past, present, or prospective business relationship with the Company, and

 

 

(d)

names, addresses and contact information of past, present or prospective suppliers, consultants, lenders or professional advisors of the Company and prices or rates charged by them;

 

which by virtue of the Consultant’s position, the Consultant may obtain during the Term.

 

8.2

The Consultant acknowledges that the Confidential Information could be used to the detriment of the Company.  Accordingly the Consultant undertakes to treat confidentially all such information and agrees not to disclose any Confidential Information to any third party or use it for any purpose or reason without the express written permission of the Company, except as may be necessary to perform its duties, whether during the Term or thereafter.

 

8.3

For the purposes of this Agreement, Confidential Information shall not include any information which the Consultant can prove by competent evidence, is:

 

 

(a)

now, or hereafter becomes, through no act or failure to act on the part of the Consultant, generally known or available to the public;

 

 

(b)

known by the Consultant at the time of receiving such information, as evidenced by its records;

 

 

(c)

hereafter furnished to the Consultant without restriction as to disclosure or used by a third party lawfully entitled to furnish such information;

 

 

(d)

independently developed by the employees, agents or contractors of the Consultant without the aid, application or use of the Confidential Information; or

 

 

(e)

the subject of a written permission to disclose provided by the Company.

 

 

4


 


 

9. 

REPRESENTATIONS AND WARRANTIES

 

9.1

The Consultant represents, warrants and covenants to the Company that the Consultant is and will remain, during the Term, qualified and licensed to practice law in the Province of British Columbia and the State of Washington.

 

10. 

INDEMNIFICATION

 

10.1

The Company agrees to indemnify and hold harmless the Consultant and its respective agents and employees against any losses, claims, damages or liabilities, joint or several, to which either party, or any such other person, may become subject, insofar as such losses, claims, damages or liabilities (or actions, suits or proceedings in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in any registration statement, preliminary prospectus, prospectus or any amendment or supplement thereto; or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; and shall reimburse the Consultant, or any such other person, for any legal or other expenses reasonably incurred by the Consultant, or any such other person, in connection with investigating or defending any such loss, claim, damage, liability, or action, suit or proceeding.

 

10.2

The Consultant agrees to indemnify and hold harmless the Company, its partners, financiers, parent, affiliated and related companies and all of their respective individual shareholders, directors, officers, employees, licensees and assigns from and against any claims, actions, losses and expenses (including legal expenses) occasioned by any breach of the Consultant’s representations and warranties contained in this Agreement, or by any breach of any other provision hereof by the Consultant.

 

11. 

MISCELLANEOUS PROVISIONS

 

11.1

Time .  Time is of the essence of this Agreement.

 

11.2

Presumption .  This Agreement or any section thereof shall not be construed against any party due to the fact that said Agreement or any section thereof was drafted by said party.

 

11.3

Titles and Captions .  All article, section and paragraph titles or captions contained in this Agreement are for convenience only and shall not be deemed part of the context nor affect the interpretation of this Agreement.

 

11.4

Further Action .  The parties hereto shall execute and deliver all documents, provide all information and take or forbear from all such action as may be necessary or appropriate to achieve the purposes of this Agreement.

 

 

5


 


 

11.5

Good Faith, Cooperation and Due Diligence .  The parties hereto covenant, warrant and represent to each other good faith, complete cooperation, due diligence and honesty in fact in the performance of all obligations of the parties pursuant to this Agreement.  All promises and covenants are mutual and dependent.

 

11.6

Savings Clause .  If any provision of this Agreement, or the application of such provision to any person or circumstance, shall be held invalid, the remainder of this Agreement, or the application of such provision to persons or circumstances other than those as to which it is held invalid, shall not be affected thereby.

 

11.7

Assignment .  This Agreement may not be assigned by either party hereto without the written consent of the other party.

 

11.8

Notices .  All notices required or permitted to be given under this Agreement shall be given in writing and shall be delivered, either personally or by express delivery service, to the party to be notified.

 

11.9

Entire Agreement .  This Agreement, including Schedule “A”” attached hereto, contains the entire understanding and agreement between the parties. There are no other agreements, conditions or representations, oral or written, express or implied, with regard thereto.

 

11.10

Amendment .  This Agreement may only be amended in writing signed by the parties hereto.

 

11.11

Waiver .  A delay or failure by any party to exercise a right under this Agreement, or a partial or single exercise of that right, shall not constitute a waiver of that or any other right.

 

11.12

Counterparts .  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same Agreement.  In the event that this Agreement is signed by one party and faxed to another, the parties agree that a faxed signature shall be binding upon the parties as though the signature was an original.

 

11.13

Successors .  The provisions of this Agreement shall be binding upon the parties, their successors and permitted assigns.

 

11.14

Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the Province of British Columbia, Canada and the laws of Canada applicable therein.  The parties hereby attorn the exclusive jurisdiction of the provincial and federal courts located in the city of Vancouver, British Columbia in relation to all disputes arising from this Agreement.

 

11.15

Counsel .  The parties expressly acknowledge that each has been advised to seek separate counsel for advice in this matter and has been given a reasonable opportunity to do so.

 

 

6


 

 

IN WITNESS WHEREOF the parties have executed this Agreement as of the date first written above.

 

 

NEUROKINE PHARMACEUTICALS INC.

 

 

 

Per:     /s/ Ahmad Doroudian

     Ahmad Doroudian

     President and Chief Executive Officer                                                                                                

 

 

PENNY GREEN

 

/s/ Penny Green

Penny Green

 

 

7


 

SCHEDULE “A”

 

NEUROKINE PHARMACEUTICALS INC.

 

SUBSCRIPTION AGREEMENT

(THE “AGREEMENT”)

 

The undersigned subscriber (the “Subscriber”) hereby subscribes for and agrees to purchase 48,000 common shares in the capital stock of Neurokine Pharmaceuticals Inc. (the “Company”) at a price of US$ _____________ per share (the “Shares”) for aggregate proceeds of US$ _____________ (the “Funds”), all on the terms and subject to the conditions set forth in Exhibit “A” attached hereto.

 

EXECUTION BY SUBSCRIBER

 

______________________

Tax ID or Social Insurance Number

 

Penny Green

Name of Subscriber

 

Provision of Services

Payment Method

 

 

_____________________________________

Signature of Individual Subscriber or

Authorized Signatory of Subscriber

(if Subscriber not an individual)

 

 

 

_____________________________________

Number and type of securities of the Company

directly and indirectly held by Subscriber

 

 

925 West Georgia Street, Suite 1820

 

Vancouver, British Columbia V6C 3L2

Address of Subscriber

 

_____________________________________

Name of Contact Person, if Subscriber not an individual

 

(604) 632-1700

Telephone Number of Subscriber or Contact Person

 

(604) 632-1730

Facsimile Number of Subscriber or Contact Person

 

Executed by the Subscriber this 1st day of April, 2009.

 

 

8


 

 

Please complete the following section if you require the certificate(s) representing the Shares to appear in the name of an intermediary, such as your broker, or require the certificate(s) to be delivered to an address other than that shown above.

 

REGISTRATION INSTRUCTIONS

DELIVERY INSTRUCTIONS

 

Penny Green

Name to appear on certificate(s)

 

_____________________________________

Name and account reference, if applicable

 

_____________________________________

Account reference, if applicable

 

_____________________________________

Contact Person

 

_____________________________________

 

_____________________________________

Address of Intermediary

 

_____________________________________

 

As Above

Address for Delivery

 

ACCEPTED by the Company this __________ day of ________________, 2009.

 

NEUROKINE PHARMACEUTICALS INC.

 

 

Per:     /s/ Ahmad Doroudian

     Ahmad Doroudian

     President and Chief Executive Officer

 

 

9


 

Exhibit “A” To Subscription Agreement

 

In consideration of the covenants and agreements in this Agreement, and the payment of one dollar made by each party to the other, the receipt and sufficiency of which is acknowledged by each party, the parties agree as follows:

 

Delivery of Documents and Funds

 

The Subscriber hereby delivers to the Company:

 

1.

a completed and executed copy of this Agreement; for all Subscribers: a completed and executed Investor Exemptions Questionnaire attached as Exhibit “B” and in the case of a subscription for the Shares by the Subscriber acting as trustee or agent for a principal, the Subscriber shall provide the Company with an Accredited Investor Questionnaire in the form set forth in Exhibit “B” for each trust, beneficial owner and/or principal for which the Subscriber is acting as trustee or agent;

 

2.

if the Subscriber is a U.S. Person, additionally: a completed and executed Accredited Investor Questionnaire attached as Exhibit “C” and in the case of a subscription for the Shares by the Subscriber acting as trustee or agent for a principal, the Subscriber shall provide the Company with an Accredited Investor Questionnaire in the form set forth in Exhibit “C” for each trust, beneficial owner and/or principal for which the Subscriber is acting as trustee or agent; and

 

 

 

3.

unless an alternate payment method has been agreed upon in writing, a certified check or bank draft for the Funds made payable to “Neurokine Pharmaceuticals Inc.”.

 

Closing

 

The closing of the transactions contemplated by this Agreement (the “Closing”) will take place within 10 business days of the receipt of this Agreement by the Company.  

 

At the Closing, the Company will deliver to the Subscriber the certificates representing the Shares and an agreement representing the Shares purchased by the Subscriber registered in the name of the Subscriber or as directed on the cover page of this Agreement.

 

 

10


 


 

Subscriber’s Representations, Warranties, Covenants, Acknowledgements and Agreements

 

1.

The Subscriber represents and warrants to the Company, and acknowledges that the Company is relying on these representations and warranties to, among other things, ensure that it is complying with all of the applicable securities legislation, that:

 

 

(a) 

the Subscriber is purchasing as principal and is either: 

 

 

(i)

not a U.S. person and is not acquiring the Shares for the account or benefit of any U.S. person; OR

 

 

(ii)

a U.S. person who is purchasing the Shares in a transaction that does not require registration under the U.S. Securities Act.

 

 

(b)

if the Subscriber is a resident of an “International Jurisdiction” (which means a jurisdiction other than British Columbia), then:

 

 

(i)

the Subscriber is knowledgeable of, or has been independently advised as to, the applicable securities legislation of the International Jurisdiction which would apply to this subscription, if there are any;

 

 

 

 

(ii)

the Subscriber is purchasing the Shares pursuant to exemptions under the securities legislation of that International Jurisdiction or, if such is not applicable, the Subscriber is permitted to purchase the Shares under the applicable securities legislation of the International Jurisdiction without the need to rely on exemptions; and

 

 

 

 

(iii)

the applicable securities legislation does not require the Company to make any filings or seek any approvals of any kind whatsoever from any regulatory authority of any kind whatsoever in the International Jurisdiction; and

 

the Subscriber will, if requested by the Company, deliver to the Company a certificate or opinion of loca


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more